Compare AGNC & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGNC | PODD |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 10.2B |
| IPO Year | 2008 | 2007 |
| Metric | AGNC | PODD |
|---|---|---|
| Price | $10.19 | $132.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 21 |
| Target Price | $11.03 | ★ $341.48 |
| AVG Volume (30 Days) | ★ 15.8M | 1.6M |
| Earning Date | 04-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 13.13% | N/A |
| EPS Growth | ★ 58.06 | N/A |
| EPS | 0.37 | ★ 2.67 |
| Revenue | N/A | ★ $2,708,100,000.00 |
| Revenue This Year | $0.33 | $24.55 |
| Revenue Next Year | $1.16 | $19.18 |
| P/E Ratio | ★ $28.49 | $51.66 |
| Revenue Growth | N/A | ★ 30.73 |
| 52 Week Low | $9.63 | $126.40 |
| 52 Week High | $12.19 | $354.88 |
| Indicator | AGNC | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 31.45 | 33.98 |
| Support Level | $10.28 | $126.40 |
| Resistance Level | $10.64 | $153.33 |
| Average True Range (ATR) | 0.17 | 5.01 |
| MACD | -0.05 | -0.62 |
| Stochastic Oscillator | 6.25 | 1.22 |
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.